RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment
Norihito Yonenaga(University of Shizuoka), Naoto Oku(University of Shizuoka), Takehisa Dewa(Nagoya Institute of Technology), Mamoru Nango(Nagoya Institute of Technology), Kosuke Shimizu(Hamamatsu Photonics (Japan)), Atsushi Tsuruta, Tomohiro Asai(University of Shizuoka), Eriya Kenjo(Takeda (Japan))
Cited by 83
Related Papers
Recognition, Neutralization, and Clearance of Target Peptides in the Bloodstream of Living Mice by Molecularly Imprinted Polymer Nanoparticles: A Plastic Antibody
|Journal of the American Chemical Society|2010|486
Tyrosine Phosphorylation of β-Catenin and Plakoglobin Enhanced by Hepatocyte Growth Factor and Epidermal Growth Factor in Human Carcinoma Cells
|Cell Communication & Adhesion|1994|417
Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
|Nature Communications|2021|277
Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor
|Journal of Biological Chemistry|1993|256
The rational design of a synthetic polymer nanoparticle that neutralizes a toxic peptide in vivo
|Proceedings of the National Academy of Sciences|2011|202